In mouse models, CS3002 combined with PD-1 monoclonal
antibody therapy or endocrine therapy has shown improved tumor suppressing activities compared to monotherapies.
ENPNewswire-August 2, 2019--Queen Mary University of London: Promising
antibody therapy extends survival in mice with pancreatic cancer
This new patent builds upon NantKwest's extensive existing patent estate and broadens the company's established intellectual property combining haNK natural killer cell therapy together with
antibody therapy. This novel engineered haNK cell product represents the core foundational element of the Company's haNK therapeutics program.
Llamas, better known for its wool, have been used to produce a new
antibody therapy that has the potential to work against all types of flu, including new pandemics.
ISLAMABAD -- Hitting two targets on the cancer cell could greatly increase the power of
antibody therapy to kill ovarian cancer.
The study will test the subcutaneous bermekimab therapy in AD patients after only 4 or 8 weeks of treatment, compared with the 16 week treatment regimen currently used for the only approved
antibody therapy for AD.
Bradley was treated with the
antibody therapy, among other treatments, during his first fight with the illness which started in 2013.
Merina Thomas, M.D., from the University of Michigan in Ann Arbor, and colleagues describe three patients who developed uveal effusion after initiation of anti-PD-1 and anti-PD-L1 monoclonal
antibody therapy. The patients were two white men aged 52 and 85 years with metastatic cutaneous melanoma and a 68-year-old African-American man with metastatic adenocarcinoma of the lung.
Nexvet's pipeline product ranevetmab, a mAb targeting nerve-growth factor for treatment of chronic pain associated with osteoarthritis in dogs, would, upon approval, be the companion animal industry's first monoclonal
antibody therapy administered monthly by injection for chronic pain.
Biopharmaceutical company Cantargia AB (STO: CANTA.ST) announced on Wednesday that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance on Its patent application regarding IL1RAP as a target molecule for
antibody therapy of acute lymphatic leukaemia (ALL).
Against the EGFR-targeted monoclonal
antibody therapy, when applied across all treatment lines either as a single agent or in combination with chemotherapy, the mutation could indicate the therapy's non-responsiveness.
Filings: XBiotech has been granted Fast Track Designation for its novel True Human monoclonal
antibody therapy intended to treat all forms of Staphylococcus aureus infections, including Methicillin-resistant S.
